Overlap of autoimmune hepatitis and primary biliary cirrhosis: Long-term outcomes

American Journal of Gastroenterology

Volumn 102, Issue 6, 2007, Pages 1244-1250

  Silveira, Marina G ^a   Talwalkar, Jayant A ^a   Angulo, Paul ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; BRAIN DISEASE; CONTROLLED STUDY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PORTAL HYPERTENSION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SCORING SYSTEM;

ASCITES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATITIS, AUTOIMMUNE; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SYNDROME; URSODEOXYCHOLIC ACID;

EID: 34249023304     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01136.x     Document Type: Article

References (15)

1. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996 125 : 588 98.
2. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998 28 : 360 5.
3. Talwalkar JA, Keach JC, Angulo P, et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis: An evaluation of a modified scoring system. Am J Gastroenterol 2002 97 : 1191 7.
4. Chazouilleres O, Wendum D, Serfaty L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology 1998 28 : 296 301.
5. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993 18 : 998 1005.
6. Czaja A, Carpenter HA. Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 1996 41 : 305 14.
7. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999 31 : 929 38.
8. Poupon RE, Lindor KD, Cauch-Dudek K, et al. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997 113 : 884 90.
9. Cook GC, Mulligan R, Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971 40 : 159 85.
10. Lohse AW, zum Buschenfelde KH, Franz B, et al. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999 29 : 1078 84.
11. Heathcote EJ. Overlap of autoimmune hepatitis and primary biliary cirrhosis: An evaluation of a modified scoring system. Am J Gastroenterol 2002 97 : 1090 2.
12. Joshi S, Cauch-Dudek K, Wanless IR, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: Response to therapy with ursodeoxycholic acid. Hepatology 2002 35 : 409 13.
13. Dickson ER, Grambsch PM, Fleming TR, et al. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989 10 : 1 7.
14. Chazouilleres O, Wendum D, Serfaty L, et al. Long-term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2006 44 : 400 406.
15. Czaja AJ. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: A foray across diagnostic boundaries. J Hepatol 2006 44 : 251 2.